Rapidly progressive course of pauci-immune pulmonary capillaritis in a 70-year-old Asian male refractory to immunosuppression and plasma exchange.
Autor: | Jiang C; Pulmonary Medicine, Jamaica Hospital Medical Center, Jamaica, New York, USA cjiangmd@yahoo.com., Martinez Pena GN; Pulmonary Medicine, Jamaica Hospital Medical Center, Jamaica, New York, USA., Xie M; Medicine - Clinical Research, Jamaica Hospital Medical Center, Jamaica, New York, USA., Gafoor K; Pulmonary Medicine, Jamaica Hospital Medical Center, Jamaica, New York, USA. |
---|---|
Jazyk: | angličtina |
Zdroj: | BMJ case reports [BMJ Case Rep] 2020 Mar 12; Vol. 13 (3). Date of Electronic Publication: 2020 Mar 12. |
DOI: | 10.1136/bcr-2019-233577 |
Abstrakt: | A 70-year-old man presented with acute respiratory failure, alveolar infiltrates and haemoptysis requiring supplemental oxygen. Flexible bronchoscopy with bronchoalveolar lavage identifies diffuse alveolar haemorrhage. Clinical and serological evaluations do not identify a precise aetiology and histopathology establishes the diagnosis of isolated pauci-immune pulmonary capillaritis. The patient received induction therapy with high dose methylprednisolone at 1000 mg/day for 5 days and weekly rituximab at 375 mg/m 2 scheduled over 4 weeks. Although the patient demonstrated clinical improvement after the first week, he experienced a rapid relapse requiring mechanical ventilation. His induction rituximab regimen was continued and plasma exchange was initiated. Despite these therapies, the patient's condition deteriorated and passed away. Our case adds insight to the management of this rare entity and describes the use of plasma exchange as salvage therapy. Competing Interests: Competing interests: None declared. (© BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.) |
Databáze: | MEDLINE |
Externí odkaz: |